Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The protean ocular involvement in monogenic autoinflammatory diseases: state of the art.
Bascherini V, Granato C, Lopalco G, Emmi G, Vannozzi L, Bacherini D, Franceschini R, Iannone F, Salerni A, Molinaro F, Messina M, Frediani B, Selmi C, Rigante D, Cantarini L. Bascherini V, et al. Among authors: vannozzi l. Clin Rheumatol. 2015 Jul;34(7):1171-80. doi: 10.1007/s10067-015-2920-3. Epub 2015 Apr 2. Clin Rheumatol. 2015. PMID: 25833143 Review.
Ocular safety of infliximab in rabbit and cell culture models.
Giansanti F, Papucci L, Capaccioli S, Bacherini D, Vannozzi L, Witort E, Menchini U. Giansanti F, et al. Among authors: vannozzi l. J Ocul Pharmacol Ther. 2010 Feb;26(1):65-71. doi: 10.1089/jop.2009.0035. J Ocul Pharmacol Ther. 2010. PMID: 20148652
Successful treatment of ocular sarcoidosis with rituximab.
Beccastrini E, Vannozzi L, Bacherini D, Squatrito D, Emmi L. Beccastrini E, et al. Among authors: vannozzi l. Ocul Immunol Inflamm. 2013 Jun;21(3):244-6. doi: 10.3109/09273948.2012.762982. Epub 2013 Mar 12. Ocul Immunol Inflamm. 2013. PMID: 23480604 No abstract available.
Anakinra for resistant Behçet uveitis: why not?
Emmi G, Silvestri E, Cameli AM, Bacherini D, Vannozzi L, Squatrito D, Emmi L. Emmi G, et al. Among authors: vannozzi l. Clin Exp Rheumatol. 2013 May-Jun;31(3 Suppl 77):152-3. Epub 2013 Sep 9. Clin Exp Rheumatol. 2013. PMID: 24064028 No abstract available.
Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study.
Fabiani C, Vitale A, Emmi G, Vannozzi L, Lopalco G, Guerriero S, Orlando I, Franceschini R, Bacherini D, Cimino L, Soriano A, Frediani B, Galeazzi M, Iannone F, Tosi GM, Salvarani C, Cantarini L. Fabiani C, et al. Among authors: vannozzi l. Clin Rheumatol. 2017 Jan;36(1):183-189. doi: 10.1007/s10067-016-3480-x. Epub 2016 Nov 16. Clin Rheumatol. 2017. PMID: 27853889
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet's disease-related uveitis: a multicenter retrospective observational study.
Fabiani C, Vitale A, Emmi G, Lopalco G, Vannozzi L, Guerriero S, Gentileschi S, Bacherini D, Franceschini R, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L. Fabiani C, et al. Among authors: vannozzi l. Clin Rheumatol. 2017 Jan;36(1):191-197. doi: 10.1007/s10067-016-3506-4. Epub 2016 Dec 16. Clin Rheumatol. 2017. PMID: 27981463
79 results